Related Experiment Videos
The HIF pathway as a therapeutic target
Kirsty S Hewitson1, Christopher J Schofield
1Oxford Centre for Molecular Sciences and the Department of Chemistry, Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK. kirsty.hewitson@chem.ox.ac.uk
Drug Discovery Today
|September 3, 2004
Summary
The Hypoxia-Inducible Factor (HIF) pathway regulates genes for tumor growth and blood vessel formation. Targeting this pathway offers potential treatments for cancer and ischemic diseases.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Hypoxia-inducible factor (HIF) is a key transcription factor regulating cellular responses to low oxygen.
- HIF controls genes vital for tumorogenesis and angiogenesis.
- The HIF pathway is a promising therapeutic target for cancer and ischemic diseases.
Purpose of the Study:
- To review the role of the HIF pathway in cellular responses to hypoxia.
- To highlight the therapeutic potential of targeting the HIF pathway.
- To discuss the regulation of HIF-alpha subunit activity.
Main Methods:
- Review of existing literature on HIF pathway.
- Analysis of molecular mechanisms regulating HIF.
- Discussion of therapeutic strategies targeting HIF.
Main Results:
- HIF-alpha subunit levels and activity are regulated by posttranslational hydroxylation.
- Fe(II)- and 2-oxoglutarate-dependent oxygenases catalyze HIF-alpha hydroxylation.
- HIF pathway modulation is crucial for managing diseases like cancer and ischemia.
Conclusions:
- The HIF pathway is a critical regulator of cellular adaptation to hypoxia.
- Targeting HIF offers a viable strategy for treating various diseases.
- Understanding HIF regulation is key to developing effective therapies.